Skip to main content
Erschienen in: Cancer Chemotherapy and Pharmacology 3/2019

17.04.2019 | Original Article

Electrophysiologic evaluation of facial nerve functions after oxaliplatin treatment

verfasst von: Oznur Yigit, Mavis Emel Kulak Kayikci, Cagri Mesut Temucin, Sarp Sarac, Mustafa Erman, Erol Belgin

Erschienen in: Cancer Chemotherapy and Pharmacology | Ausgabe 3/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

This study analyzes the effect of oxaliplatin treatment on the facial nerve. The facial nerve is the most commonly paralyzed cranial motor nerve because it advances through a long, curved bone canal. Electroneurography and blink reflex are the electrophysiological measurements used for evaluating facial nerve function. Oxaliplatin is a cytotoxic agent used in adjuvant or palliative systemic therapy for colorectal cancer treatment.

Methods

This study was performed on 20 individuals who were at least 18 years old at Hacettepe University Ear Nose Throat Department, Audiology and Speech Disorders Unit, and Neurology Division EMG Laboratory as they received oxaliplatin treatment from Hacettepe University Oncology Hospital. Electroneurography and blink-reflex values were recorded and examined. The parameters taken during the second and fourth months were compared for this purpose.

Results

This study shows that the prolongation of distal latencies of compound muscle action potential is statistically significant, the amplitudes showed no difference. The ENoG results were analyzed, the prolongation of latency measurements between pre-treatment and the fourth month after treatment were statistically significant. The blink-reflex results showed that comparison with the baseline values, the prolongation of latencies in R1 measurements between pre-treatment, the second month, and the fourth month were significant.

Conclusions

The facial nerve is affected asymptomatically by oxaliplatin treatment. During oxaliplatin treatment, the evaluation of facial nerve function could be beneficial for patients by improving their quality of life. Electroneurography and blink-reflex tests can be used in the early evaluations of different medicines to determine their neurotoxicity.
Literatur
1.
Zurück zum Zitat Quasthoff S, Hartung HP (2002) Chemotherapy-induced peripheral neuropathy. J Neurol 249(1):9–17CrossRefPubMed Quasthoff S, Hartung HP (2002) Chemotherapy-induced peripheral neuropathy. J Neurol 249(1):9–17CrossRefPubMed
2.
Zurück zum Zitat Custodio A, Moreno-Rubio J, Aparicio J, Gallego-Plazas J, Yaya R, Maurel J et al (2013) Pharmacogenetic predictors of severe peripheral neuropathy in colon cancer patients treated with oxaliplatin-based adjuvant chemotherapy: a GEMCAD group study. Ann Oncol 25(2):398–403CrossRefPubMed Custodio A, Moreno-Rubio J, Aparicio J, Gallego-Plazas J, Yaya R, Maurel J et al (2013) Pharmacogenetic predictors of severe peripheral neuropathy in colon cancer patients treated with oxaliplatin-based adjuvant chemotherapy: a GEMCAD group study. Ann Oncol 25(2):398–403CrossRefPubMed
3.
Zurück zum Zitat André T, Boni C, Mounedji-Boudiaf L, Navarro M, Tabernero J, Hickish T et al (2004) Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 350(23):2343–2351CrossRefPubMed André T, Boni C, Mounedji-Boudiaf L, Navarro M, Tabernero J, Hickish T et al (2004) Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 350(23):2343–2351CrossRefPubMed
4.
Zurück zum Zitat Lièvre A, Samalin E, Mitry E, Assenat E, Boyer-Gestin C, Lepère C et al (2009) Bevacizumab plus FOLFIRI or FOLFOX in chemotherapy-refractory patients with metastatic colorectal cancer: a retrospective study. BMC Cancer. 9(1):347CrossRefPubMedPubMedCentral Lièvre A, Samalin E, Mitry E, Assenat E, Boyer-Gestin C, Lepère C et al (2009) Bevacizumab plus FOLFIRI or FOLFOX in chemotherapy-refractory patients with metastatic colorectal cancer: a retrospective study. BMC Cancer. 9(1):347CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Cersosimo RJ (2005) Oxaliplatin-associated neuropathy: a review. Ann Pharmacother 39(1):128–135CrossRefPubMed Cersosimo RJ (2005) Oxaliplatin-associated neuropathy: a review. Ann Pharmacother 39(1):128–135CrossRefPubMed
6.
Zurück zum Zitat Esslen E. The acute facial palsies: investigations on the localization and pathogenesis of meato-labyrinthine facial palsies: Springer Science & Business Media; 2012 Esslen E. The acute facial palsies: investigations on the localization and pathogenesis of meato-labyrinthine facial palsies: Springer Science & Business Media; 2012
7.
Zurück zum Zitat VanSwearingen JM, Cohn JF, Bajaj-Luthra A (1999) Specific impairment of smiling increases the severity of depressive symptoms in patients with facial neuromuscular disorders. Aesthetic Plast Surg 23(6):416–423CrossRefPubMed VanSwearingen JM, Cohn JF, Bajaj-Luthra A (1999) Specific impairment of smiling increases the severity of depressive symptoms in patients with facial neuromuscular disorders. Aesthetic Plast Surg 23(6):416–423CrossRefPubMed
8.
Zurück zum Zitat Ardic FN, Ardic F, Topaloglu J, Öncel S, Uguz MZ, Topalogu D (1997) Electroneurography in the late period of Bell’s palsy. Acta Otolaryngol 117(3):325–328CrossRefPubMed Ardic FN, Ardic F, Topaloglu J, Öncel S, Uguz MZ, Topalogu D (1997) Electroneurography in the late period of Bell’s palsy. Acta Otolaryngol 117(3):325–328CrossRefPubMed
9.
Zurück zum Zitat Lee KJ (2015) KJ Lee’s essential otolaryngology, 11th edn. McGraw-Hill Education, New York Lee KJ (2015) KJ Lee’s essential otolaryngology, 11th edn. McGraw-Hill Education, New York
10.
Zurück zum Zitat Ardic F, Ardic F, Topaloglu J, Öncel S, Uguz M, Topalogu D (1997) Electroneurography in the late period of Bell’s palsy. Acta Otolaryngol 117(3):325–328CrossRefPubMed Ardic F, Ardic F, Topaloglu J, Öncel S, Uguz M, Topalogu D (1997) Electroneurography in the late period of Bell’s palsy. Acta Otolaryngol 117(3):325–328CrossRefPubMed
11.
Zurück zum Zitat Akkuzu B (2008) Fasiyal Sinir Hastalıklarında Muayene ve Tanı Teknikleri. Türkiye Klinikleri Kulak Burun Boğaz Özel Dergisi. 1(1):8 Akkuzu B (2008) Fasiyal Sinir Hastalıklarında Muayene ve Tanı Teknikleri. Türkiye Klinikleri Kulak Burun Boğaz Özel Dergisi. 1(1):8
12.
Zurück zum Zitat Hall JWI. Nonauditory clinical neurophysiology. In: D. DS (ed). New handbook of auditory evoked responses. USA: Pearson Education; 2007 Hall JWI. Nonauditory clinical neurophysiology. In: D. DS (ed). New handbook of auditory evoked responses. USA: Pearson Education; 2007
13.
Zurück zum Zitat Cruccu G, Deuschl G (2000) The clinical use of brainstem reflexes and hand-muscle reflexes. Clin Neurophysiol 111(3):371–387CrossRefPubMed Cruccu G, Deuschl G (2000) The clinical use of brainstem reflexes and hand-muscle reflexes. Clin Neurophysiol 111(3):371–387CrossRefPubMed
14.
Zurück zum Zitat Gültekin M, Boztaş G (2014) Türkiye kanser istatistikleri. Türkiye Halk Sağlığı Kurumu, Sağlık Bakanlığı, p 43 Gültekin M, Boztaş G (2014) Türkiye kanser istatistikleri. Türkiye Halk Sağlığı Kurumu, Sağlık Bakanlığı, p 43
15.
Zurück zum Zitat Pasetto LM, D’Andrea MR, Rossi E, Monfardini S (2006) Oxaliplatin-related neurotoxicity: how and why? Crit Rev Oncol/Hematol 59(2):159–168CrossRef Pasetto LM, D’Andrea MR, Rossi E, Monfardini S (2006) Oxaliplatin-related neurotoxicity: how and why? Crit Rev Oncol/Hematol 59(2):159–168CrossRef
16.
Zurück zum Zitat Kannarkat G, Lasher EE, Schiff D (2007) Neurologic complications of chemotherapy agents. Curr Opin Neurol 20(6):719–725PubMed Kannarkat G, Lasher EE, Schiff D (2007) Neurologic complications of chemotherapy agents. Curr Opin Neurol 20(6):719–725PubMed
17.
Zurück zum Zitat Griffith KA, Zhu S, Johantgen M, Kessler MD, Renn C, Beutler AS et al (2017) Oxaliplatin-induced peripheral neuropathy and identification of unique severity groups in colorectal cancer. J Pain Symptom Manag. 54(5):701-6. e1CrossRef Griffith KA, Zhu S, Johantgen M, Kessler MD, Renn C, Beutler AS et al (2017) Oxaliplatin-induced peripheral neuropathy and identification of unique severity groups in colorectal cancer. J Pain Symptom Manag. 54(5):701-6. e1CrossRef
18.
Zurück zum Zitat Pulvers JN, Marx G (2017) Factors associated with the development and severity of oxaliplatin-induced peripheral neuropathy: a systematic review. Asia-Pac J Clin Oncol 13(6):345–355CrossRefPubMed Pulvers JN, Marx G (2017) Factors associated with the development and severity of oxaliplatin-induced peripheral neuropathy: a systematic review. Asia-Pac J Clin Oncol 13(6):345–355CrossRefPubMed
19.
Zurück zum Zitat Akkuzu B (2008) Fasiyal Sinir Hastalıklarında Muayene ve Tanı Teknikleri. Turkiye Klinikleri J Ear Nose Throat-Spec Topics. 1(1):8–13 Akkuzu B (2008) Fasiyal Sinir Hastalıklarında Muayene ve Tanı Teknikleri. Turkiye Klinikleri J Ear Nose Throat-Spec Topics. 1(1):8–13
20.
Zurück zum Zitat Adelsberger H, Quasthoff S, Grosskreutz J, Lepier A, Eckel F, Lersch C (2000) The chemotherapeutic oxaliplatin alters voltage-gated Na + channel kinetics on rat sensory neurons. Eur J Pharmacol 406(1):25–32CrossRefPubMed Adelsberger H, Quasthoff S, Grosskreutz J, Lepier A, Eckel F, Lersch C (2000) The chemotherapeutic oxaliplatin alters voltage-gated Na + channel kinetics on rat sensory neurons. Eur J Pharmacol 406(1):25–32CrossRefPubMed
21.
Zurück zum Zitat Baba M, Fowler CJ, Jacobs JM, Gilliatt RW (1982) Changes in peripheral nerve fibres distal to a constriction. J Neurol Sci 54(2):197–208CrossRefPubMed Baba M, Fowler CJ, Jacobs JM, Gilliatt RW (1982) Changes in peripheral nerve fibres distal to a constriction. J Neurol Sci 54(2):197–208CrossRefPubMed
22.
Zurück zum Zitat Logician EL, Kelly JJ, Adelman LS (1994) Nerve conduction and biopsy correlation in over 100 consecutive patients with suspected polyneuropathy. Muscle Nerve 17(9):1010–1020CrossRef Logician EL, Kelly JJ, Adelman LS (1994) Nerve conduction and biopsy correlation in over 100 consecutive patients with suspected polyneuropathy. Muscle Nerve 17(9):1010–1020CrossRef
23.
Zurück zum Zitat Feinberg DM, Preston DC, Shefner JM, Logigian EL (1999) Amplitude-dependent slowing of conduction in amyotrophic lateral sclerosis and polyneuropathy. Muscle Nerve 22(7):937–940CrossRefPubMed Feinberg DM, Preston DC, Shefner JM, Logigian EL (1999) Amplitude-dependent slowing of conduction in amyotrophic lateral sclerosis and polyneuropathy. Muscle Nerve 22(7):937–940CrossRefPubMed
24.
Zurück zum Zitat Lehky TJ, Leonard GD, Wilson RH, Grem JL, Floeter MK (2004) Oxaliplatin-induced neurotoxicity: acute hyperexcitability and chronic neuropathy. Muscle Nerve 29(3):387–392CrossRefPubMed Lehky TJ, Leonard GD, Wilson RH, Grem JL, Floeter MK (2004) Oxaliplatin-induced neurotoxicity: acute hyperexcitability and chronic neuropathy. Muscle Nerve 29(3):387–392CrossRefPubMed
25.
Zurück zum Zitat Kazem SS, Behzad D (2006) Role of blink reflex in diagnosis of subclinical cranial neuropathy in diabetic mellitus type II. Am J Phys Med Rehabil 85(5):449–452CrossRefPubMed Kazem SS, Behzad D (2006) Role of blink reflex in diagnosis of subclinical cranial neuropathy in diabetic mellitus type II. Am J Phys Med Rehabil 85(5):449–452CrossRefPubMed
26.
Zurück zum Zitat Casale R, Frazzitta G, Fundarò C, Balbi P, Rosso AD, Bertinotti L et al (2004) Blink reflex discloses CNS dysfunction in neurologically asymptomatic patients with systemic sclerosis. Clin Neurophysiol 115(8):1917–1920CrossRefPubMed Casale R, Frazzitta G, Fundarò C, Balbi P, Rosso AD, Bertinotti L et al (2004) Blink reflex discloses CNS dysfunction in neurologically asymptomatic patients with systemic sclerosis. Clin Neurophysiol 115(8):1917–1920CrossRefPubMed
27.
Zurück zum Zitat Cruccu G, Iannetti GD, Marx JJ, Thoemke F, Truini A, Fitzek S et al (2005) Brainstem reflex circuits revisited. Brain 128(2):386–394CrossRefPubMed Cruccu G, Iannetti GD, Marx JJ, Thoemke F, Truini A, Fitzek S et al (2005) Brainstem reflex circuits revisited. Brain 128(2):386–394CrossRefPubMed
28.
Zurück zum Zitat Kimura J (1981) Conduction abnormalities of the facial and trigeminal nerves in polyneuropathy. Muscle Nerve 5(9S):S139–S144 Kimura J (1981) Conduction abnormalities of the facial and trigeminal nerves in polyneuropathy. Muscle Nerve 5(9S):S139–S144
Metadaten
Titel
Electrophysiologic evaluation of facial nerve functions after oxaliplatin treatment
verfasst von
Oznur Yigit
Mavis Emel Kulak Kayikci
Cagri Mesut Temucin
Sarp Sarac
Mustafa Erman
Erol Belgin
Publikationsdatum
17.04.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
Cancer Chemotherapy and Pharmacology / Ausgabe 3/2019
Print ISSN: 0344-5704
Elektronische ISSN: 1432-0843
DOI
https://doi.org/10.1007/s00280-019-03841-2

Weitere Artikel der Ausgabe 3/2019

Cancer Chemotherapy and Pharmacology 3/2019 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.